These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 29329285)

  • 1. A direct interaction of cholesterol with the dopamine transporter prevents its out-to-inward transition.
    Zeppelin T; Ladefoged LK; Sinning S; Periole X; Schiøtt B
    PLoS Comput Biol; 2018 Jan; 14(1):e1005907. PubMed ID: 29329285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesterol binding to a conserved site modulates the conformation, pharmacology, and transport kinetics of the human serotonin transporter.
    Laursen L; Severinsen K; Kristensen KB; Periole X; Overby M; Müller HK; Schiøtt B; Sinning S
    J Biol Chem; 2018 Mar; 293(10):3510-3523. PubMed ID: 29352106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular dynamics of conformation-specific dopamine transporter-inhibitor complexes.
    Jean B; Surratt CK; Madura JD
    J Mol Graph Model; 2017 Sep; 76():143-151. PubMed ID: 28734204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformational changes in dopamine transporter intracellular regions upon cocaine binding and dopamine translocation.
    Dehnes Y; Shan J; Beuming T; Shi L; Weinstein H; Javitch JA
    Neurochem Int; 2014 Jul; 73():4-15. PubMed ID: 24576496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. X-ray structure of dopamine transporter elucidates antidepressant mechanism.
    Penmatsa A; Wang KH; Gouaux E
    Nature; 2013 Nov; 503(7474):85-90. PubMed ID: 24037379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The substrate-driven transition to an inward-facing conformation in the functional mechanism of the dopamine transporter.
    Shan J; Javitch JA; Shi L; Weinstein H
    PLoS One; 2011 Jan; 6(1):e16350. PubMed ID: 21298009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membrane cholesterol modulates the outward facing conformation of the dopamine transporter and alters cocaine binding.
    Hong WC; Amara SG
    J Biol Chem; 2010 Oct; 285(42):32616-26. PubMed ID: 20688912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular dynamics of leucine and dopamine transporter proteins in a model cell membrane lipid bilayer.
    Gedeon PC; Indarte M; Surratt CK; Madura JD
    Proteins; 2010 Mar; 78(4):797-811. PubMed ID: 19899168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presynaptic regulation of dopamine release: Role of the DAT and VMAT2 transporters.
    Mulvihill KG
    Neurochem Int; 2019 Jan; 122():94-105. PubMed ID: 30465801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Markov State-based Quantitative Kinetic Model of Sodium Release from the Dopamine Transporter.
    Razavi AM; Khelashvili G; Weinstein H
    Sci Rep; 2017 Jan; 7():40076. PubMed ID: 28059145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A conserved salt bridge between transmembrane segments 1 and 10 constitutes an extracellular gate in the dopamine transporter.
    Pedersen AV; Andreassen TF; Loland CJ
    J Biol Chem; 2014 Dec; 289(50):35003-14. PubMed ID: 25339174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct coupling of oligomerization and oligomerization-driven endocytosis of the dopamine transporter to its conformational mechanics and activity.
    Sorkina T; Cheng MH; Bagalkot TR; Wallace C; Watkins SC; Bahar I; Sorkin A
    J Biol Chem; 2021; 296():100430. PubMed ID: 33610553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformational dynamics of a neurotransmitter:sodium symporter in a lipid bilayer.
    Adhikary S; Deredge DJ; Nagarajan A; Forrest LR; Wintrode PL; Singh SK
    Proc Natl Acad Sci U S A; 2017 Mar; 114(10):E1786-E1795. PubMed ID: 28223522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Putative drug binding conformations of monoamine transporters.
    Ravna AW; Sylte I; Kristiansen K; Dahl SG
    Bioorg Med Chem; 2006 Feb; 14(3):666-75. PubMed ID: 16216517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A juxtamembrane mutation in the N terminus of the dopamine transporter induces preference for an inward-facing conformation.
    Guptaroy B; Zhang M; Bowton E; Binda F; Shi L; Weinstein H; Galli A; Javitch JA; Neubig RR; Gnegy ME
    Mol Pharmacol; 2009 Mar; 75(3):514-24. PubMed ID: 19098122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the N-terminal dynamics on the conformational states of human dopamine transporter.
    Xu L; Chen LY
    Biophys Chem; 2022 Apr; 283():106765. PubMed ID: 35101818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Mechanism of Dopamine Transport by Human Dopamine Transporter.
    Cheng MH; Bahar I
    Structure; 2015 Nov; 23(11):2171-81. PubMed ID: 26481814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The profile of mephedrone on human monoamine transporters differs from 3,4-methylenedioxymethamphetamine primarily by lower potency at the vesicular monoamine transporter.
    Pifl C; Reither H; Hornykiewicz O
    Eur J Pharmacol; 2015 May; 755():119-26. PubMed ID: 25771452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotransmitter and psychostimulant recognition by the dopamine transporter.
    Wang KH; Penmatsa A; Gouaux E
    Nature; 2015 May; 521(7552):322-7. PubMed ID: 25970245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights from molecular dynamics: the binding site of cocaine in the dopamine transporter and permeation pathways of substrates in the leucine and dopamine transporters.
    Merchant BA; Madura JD
    J Mol Graph Model; 2012 Sep; 38():1-12. PubMed ID: 23079638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.